Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Surrozen, Inc.

Surrozen, Inc. (SRZNW) Stock Overview

Explore Surrozen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SRZNW●NASDAQ
HealthcareBiotechnology
$0.007
$0.008(53.85%)
U.S. Market opens in 15h 18m

Surrozen, Inc. (SRZNW)

Meyka AI Score

Z

Key Financials

Market Cap53.8K
P/E Ratio-0.46
EPS (TTM)$-34.49
ROE3.10%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.01
1 Year Target$0.06

SRZNW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Surrozen, Inc. (NASDAQ: SRZNW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Surrozen, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SRZNW on the NASDAQ shows an RSI of 41.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.06 for the NASDAQ listing.

Key metrics behind Surrozen, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.46 and a market capitalization of 53.8K. Combined with our AI analysis, these give both institutional and retail investors a clear view of SRZNW on the NASDAQ.

Price Performance (NASDAQ: SRZNW)

1-Day Change
-53.25%
5-Day Change
N/A
1-Month Change
-57.65%
3-Month Change
-57.65%
6-Month Change
-70.00%
Year-to-Date (YTD) Change
-64.00%
1-Year Change
-47.06%
3-Year Change
-82.61%
5-Year Change
-99.46%
All-Time (Max) Change
-99.61%

Contact Information

http://www.surrozen.com
650 489 9000
171 Oyster Point Boulevard, South San Francisco, CA, 94080

Company Facts

440 Employees
IPO DateAug 10, 2021
CountryUS
Actively Trading

Frequently Asked Questions